Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa

• Status: Completed
• Trial end date: 2004-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of the study is to rule out a harmful effect of zinc supplementation in HIV-1-infected children. The null hypothesis is that zinc supplementation will increase plasma HIV RNA levels.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Johns Hopkins Bloomberg School of Public Health
• Collaborators: Grey's Hospital; United States Agency for International Development (USAID); University of KwaZulu
• Treatments: Zinc

Criteria

Inclusion Criteria:

• HIV-infection

• 6 to 60 months of age

• Not receiving antiretroviral therapy

• Cared for as outpatients at Grey's Hospital

Exclusion Criteria:

• Receiving antiretroviral therapy